N- hydroxy- 2- ((4- phenylphenyl)sulfonylpropan- 2- yloxyamino)acetamide

Also Known As:

ARP-100

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Ischemia 01/01/2023 - "ARP-100 or ONO-4817 also reduced infarct size and cell death in hearts subjected to 45 min ischemia/120 min reperfusion. "
2.	Infarction (Infarctions) 01/01/2023 - "ARP-100 or ONO-4817 also reduced infarct size and cell death in hearts subjected to 45 min ischemia/120 min reperfusion. "
3.	Hypoxia (Hypoxemia) 08/15/2013 - "TnI degradation in neonatal cardiomyocytes was enhanced following hypoxia-reoxygenation and this was blocked by ARP-100 and Ac-LEHD-cmk. "

1.	N- hydroxy- 5- ethoxymethyloxy- 2- methyl- 4- (4- phenoxybenzoyl)aminopentanamide